ArticleBMJ case reports2020
Brief psychotic disorder associated with quarantine and mild COVID-19.
Article in BMJ case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.
- Psychosis during the COVID-19 pandemic: A systematic review of case reports and case series.Journal of psychiatric research · 2022Pooled it
- COVID-19-associated psychosis: A systematic review of case reports.General hospital psychiatryPooled it
- Comparison of Antipsychotics in the Treatment of COVID-19-Induced First-Episode Psychosis: A Review of Case Studies.Cureus · 2026Review
- Acute Schizophrenia-like Psychotic Disorder Against the Background of COVID-19.Medicina (Kaunas, Lithuania) · 2025Observational
- Clinical Features and Prognosis of Coronavirus Disease 2019-Related Psychosis: A Retrospective Case Series.Alpha psychiatry · 2023Article
- COVID-19-Associated Acute Psychotic Disorder-Longitudinal Case Report and Brief Review of Literature.Medicina (Kaunas, Lithuania) · 2023Review
- Incidence rate and distinctive characteristics of first episode psychosis during the COVID-19 pandemic: a multicenter observational study.Scientific reports · 2022Observational
- Complex Hallucinations in Hospitalized Rehabilitation Patients With COVID-19.Archives of rehabilitation research and clinical translation · 2022Article
- Article
- The Impact of the COVID-19 Virus Pandemic on the Incidence of First Psychotic Spectrum Disorders.International journal of environmental research and public health · 2022Review
- SARS-CoV-2 Psychiatric Sequelae: A Review of Neuroendocrine Mechanisms and Therapeutic Strategies.The international journal of neuropsychopharmacology · 2022Article
- COVID-19 Infection and Psychotic Experiences: Findings From the Healthy Minds Study 2020.Biological psychiatry global open science · 2021Article
- Psychiatric hospitalization during the two SARS-CoV-2 pandemic waves: New warnings for acute psychotic episodes and suicidal behaviors.World journal of psychiatry · 2021Article
- Delirious mania in a patient with COVID-19 pneumonia.BMJ case reports · 2021Article
- New-Onset Psychosis Following COVID-19 Infection.Cureus · 2021Article
- Schizophrenia during the COVID-19 pandemic.Current opinion in psychiatry · 2021Review
- Article
- Article
- Liaison Psychiatry During the Peak of the Coronavirus Pandemic: A Description of Referrals and Interventions.Frontiers in psychiatry · 2021Article
- COVID-19 associated psychosis.Industrial psychiatry journalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A 30-year-old man with no significant previous or family psychiatric history became severely anxious about his health after a positive COVID-19 test. Physical symptoms of COVID-19 were mild, with no evidence of hypoxia or pneumonia, throughout his illness. He was admitted to a quarantine facility. He remained highly anxious, and 1 week later, he developed paranoid delusions and auditory hallucinations (his first psychotic episode). He was treated with lorazepam 1 mg four times a day, mirtazapine 30 mg nocte and risperidone 1 mg two times a day. His psychotic symptoms lasted 1 week. He stopped psychiatric medication after 4 weeks and had remained well when reviewed 3 months later. A Diagnostic and Statistical Manual of Mental Disorders fifth edition diagnosis of brief psychotic disorder with marked stressor (brief reactive psychosis) was made. Anxiety about his health and social isolation appeared the main aetiological factors but an inflammatory component cannot be excluded. The case highlights that first episode psychosis can be associated with mild COVID-19.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.